Shows
AI Agents: Top Trend of 2026 - by AIAgentStore.aiPodGo — Multilingual listen/read audio briefings for commutes and quick learningLearn more about PodGo on AI Agent Store: https://aiagentstore.ai/ai-agent/podgoList of AI Agents from newest Podcast Season 3 (including upcoming episodes): https://aiagentstore.ai/collection/podcast-season-3-hubiknfakzsjList of AI Agents from Podcast Season 2: https://aiagentstore.ai/collection/podcast-season-2-vlnpozxvkssyList of AI Agents from Podcast Season 1: https://aiagentstore.ai/collection/podcast-season-1-ucqthuywrwpdFind more AI Agents: AI Agent Store.AI agents ecosystem view: https://aiagentstore.ai/ecosystem.Biggest AI agents video collection: https://aiagentstore.ai/video.Support the show...
2026-05-2203 min
The Mark Bishop ShowTMBS E396: Zach Steele - Successful Entrepreneur, COO of PodGoZach Steele is the COO and wears many more hats with the new exciting platform for Podcasters.
To support us, podcasters that place their shows on PodGo now attract serious advertisers.
Still in Beta but it advances more and more every day, Podgo.io is the go!
2026-04-1136 min
2025-09-1010 min
2025-09-0319 min
2025-08-2711 min
2025-08-2013 min
2025-08-1313 min
Best Of Becoming America: The Constitutional Convention of 1787You Are The We - David FerrieroPreservation of our founding documents and records of debates and other commentaries on the purposes and intentions of the Founders are essential to both our past and present application of the Constitution and the Bill of Rights. They are more than memories of the past, they continue to be the foundation upon which our government and liberties rest. In this final episode of Becoming America, David Ferriero, Archivist of the United States, discusses the role of the National Archives in safeguarding the original US Constitution and other founding documents. He explains how the Archives work alongside other government agencies, how...
2025-08-0958 min
The Best Of BioTech IQA Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan KobelBryan Kobel decided to pursue a career in biotech after seeing its massive opportunities to change the world. He sits down with Ammon Rivera to share how he translated his background as an investment banker into his role as the CEO of TC BioPharm, a company that develops cancer therapy. He opens up about finding his purpose in this space that allows him to save lives and molds him into a compassionate leader. Bryan also talks about their allogenic Gamma Delta T Cell therapy platform, which involves injecting isolated Gamma Delta T Cells to treat cancer-stricken patients. He explains how...
2025-08-0750 min
2025-08-0610 min
2025-07-3010 min
2025-07-2311 min
2025-07-1610 min
2025-07-0910 min2025-07-0214 min
2025-06-2512 min
2025-06-1812 min
2025-06-1112 min
2025-06-0410 min
Live SouthernThings You Need To Know Before Moving SouthLots of advice of the dos and don'ts of moving to the south.
2025-05-2819 min
Best Of Becoming America: The Constitutional Convention of 1787Our Sun Is Rising – A Group Of Americans“America is perfect idea; the United States is a work in progress.” This has been a constant theme during our “Becoming America” series. In today's society, more diverse than ever, how do the ideas that motivated our Founders stand up? Does the Constitution still resonate with the people? This episode features everyday Americans sharing their thoughts about the Constitution, which section means the most to them, and what it means to be an American. Tune in as they provide brief individual glimpses of their views of our country's ideas of liberty, opportunity, security and individual freedom.
2023-05-0257 min
Best Of Becoming America: The Constitutional Convention of 1787We, The People - Andrew GuilfordThe Preamble of the Constitution contains its most revolutionary statement, beginning with the remarkable statement that the new government would be based on the authority of “We the People.” In this episode of “Becoming America,” Dr. Jo Ellen Chatham, Judge Jim Gray, and Bijan Kian interview Judge Andrew Guilford. Retired after serving for nearly 14 years as a United States Federal District Court Judge, Judge Guilford is one of only two district judges in his region to have been invited to sit on the Federal Circuit Court of Appeals - the Ninth Circuit. In this episode, he addresses the purpose and history o...
2023-04-2555 min
Best Of Becoming America: The Constitutional Convention of 1787Someone Has Got To Decide – Dr. Gordon LloydFortunately, there are thousands of documents recording the drafting and ratification of our Constitution and the Bill of Rights. Letters, journals, newspaper articles, political pamphlets and much more provide a comprehensive account – including from both sides - those who favored and those who disapproved of the Constitution. Our guest in this episode has been shaping the conversation about our American history through his work with the Ashbrook Center. Dr. Gordon Lloyd is the Robert and Katheryn Dockson Professor of Public Policy at Pepperdine University and the creator of four highly regarded websites on the origin of the Constitution. He joins Dr...
2023-04-1852 min
Best Of Becoming America: The Constitutional Convention of 1787It’s Lonesome At The Top - George WashingtonIt can be lonesome at the top, especially when you lead not only a country but a country at the cusp of transformation. At the creation of the United States, there was one indispensable man. He commanded the Continental Army through the Revolutionary War, presided over the Constitutional Convention, and was elected to be our first President. We all know him. His name George Washington. Dr. Jo Ellen Chatham, Judge Jim Gray, and Bijan Kian have prepared a unique interview for us, diving deep into the insights and experience of the country's first Commander-in-Chief! Why did General Washington believe the Ar...
2023-04-1157 min
Best Of Becoming America: The Constitutional Convention of 1787The Studied Silence – Maj. Gen. James WilliamsWhy did our Founding Fathers ignore the issue of slavery when crafting the Constitution? To understand this better, we need to put everything in context with the times. The incipient federation was at risk of many Southern states not joining if slavery was outlawed, and many of the delegates themselves were slave owners. But to their credit, they did make the institution much less brutal. To help us gain a better understanding of this prominent and often controversial sticking point of American history, Judge Jim Gray, Professor Jo Ellen Chatham, and “The American”, Bijan Kian are joined by Major General Jame...
2023-04-0448 min
The Best Of BioTech IQBiotech Chief People Officer Discusses How To Build Company CultureScience will only get you so far in biotech. No matter how ingenious your products are, you will never succeed as a company if you don’t have all the pieces if business development in place. And there is no greater piece than the people piece. As the Chief People Officer of Biomea Fusion, Naomi Cretcher knows that company culture is what is going to make or break her company’s success. Despite everything that went on with COVID and with a recession looming, Naomi is confident that investing on their talent pool with pay off in terms of company succ...
2022-12-1838 min
The Best Of BioTech IQQualigen Therapeutics: How To Develop An Oncology Therapeutics Pipeline From A CMO's Perspective With Tariq Arshad, MDThere isn’t a cure for cancer yet, but if everyone can come together, we may find that cure sooner rather than later. One biotech company that is trying to solve cancer is Qualigen Therapeutics. With their oncology therapeutics pipeline, they could be onto something with their leading asset QN-302. Join Ammon Rivera as he talks to the Chief Medical Officer of Qualigen Therapeutics, Tariq Arshad, MD, about where they are right now in their therapeutics pipeline. Learn why cancer is the greatest injustice and how Tariq is fighting to stop it. Find out more about their research in Qualigen Therap...
2022-10-2244 min
The Best Of BioTech IQQualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy BroidrickQualigen Therapeutics is a biotechnology company that develops novel therapeutic products to treat adult and pediatric patients with rare cancers. A leading name in the industry, they have decided to build a therapeutics pipeline within the last few years. In this first episode of a three-part series featuring top executives of Qualigen Therapeutics, Ammon interviews Amy Broidrick, the firm’s President and Chief Strategy Officer. She shares what she brings to the table in the company’s transition from a preclinical stage company to a brand new business venture. She also talks about her deep love for market research, her career...
2022-09-1846 min
The Best Of BioTech IQMapping The Human Immune System: Using AI To Change Drug Development With Noam SolomonAI has gone so far as to potentially change drug development, and these developments have the potential to make a difference in people’s lives. On this episode of BioTech IQ, Ammon interviews Noam Solomon, the CEO of Immunai. Immunai is developing an AI platform that leverages big data, single cell multiomics, and machine learning to bridge the gap between casual immunology and translational disease biology. Their platform is mapping the human immune system at an unprecedented level of granularity, allowing them to identify the right targets to go after. In this interview, Noam shares his knowledge on reprogramming the im...
2022-09-0648 min
The Best Of BioTech IQGoing Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn SinghSocial anxiety disorder is the third most common mental health disorder. Over 23 million Americans alone are affected by it. This disorder can continue to grow into depression and drug abuse, so it's very important to catch it early so it can be stopped. But how can it be stopped? Shawn Singh, the CEO and Director of VistaGen Therapeutics, and his team are creating a nasal spray to help people with social anxiety disorder. Just like an inhaler for asthma, this nasal spray can do for social anxiety. Join Ammon Rivera as he talks to Shawn Singh about the PH94B n...
2022-07-2246 min
The Best Of BioTech IQHarnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel TeperCompanies in the biotech space are making contributions to help find a cure for cancer. Today’s guest is no exception. In today’s episode, Ammon Rivera sits down with Daniel Teper, Co-Founder and CEO of Cytovia Therapeutics, to talk about the unique technology they’re using to develop a treatment for cancer. Daniel discusses how they’ve developed three types of iPSC-Derived Natural Killer Cells and are now targeting unmet needs in treating hepatocellular carcinoma (HCC). There is a lot of disruptive innovation coming from the biotech industry. Daniel also discusses how the field is dealing with worsening market conditions...
2022-07-1632 min
The Best Of BioTech IQCell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro RombotisCell cycle biology is key to understanding cancer. You have to hit the cancer cells early before they become smart and adapt. There is a stage in the cell cycle called mitosis. This is where, if done right, can cause cancer cells to suicide. This is where the biotech company, Cyclacel comes in with all their research into the cell cycle of cancer. Join Ammon Rivera as he talks to Spiro Rombotis about some of Cyclacel's cell cycle therapies. Spiro is the CEO of Cyclacel. His mission is to use cell cycle biology to treat cancer and other serious diseases...
2022-06-1155 min
The Best Of BioTech IQCan Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?Have you ever thought about having replacement parts for your body? It sounds like science fiction, but it’s now as real as the eyes you’re using to read this, thanks to cell-based therapy. Brian Culley is one of the leaders in this field. He is the CEO of Lineage Cell Therapeutics, a company developing treatments for multiple indications based on their proprietary cell-based therapy platform. Leveraging in-house manufacturing, they are attacking multiple indications from ophthalmology to immuno-oncology. In this episode, Brian joins Ammon Rivera to explain what their strategy is, where they are currently in the development process, and...
2022-05-2838 minThe Best Of BioTech IQGlobal Tensions And Supply Chains And Their Effect On Biotech. Guillermo Morales, PhD, CEO Of InnoventyxThe biotech industry has been bombarded with disruptions in recent years, from a global pandemic to rising global tensions. How are they dealing with the supply chain issues and how else has it impacted the industry? In this episode, Ammon Rivera sits down with two-peat guest, Guillermo Morales, PhD, CEO of Innoventyx. Guillermo makes us privy to the issues brought on by COVID-19 and the geopolitical tensions such as the Russia-Ukraine conflict. He also discusses intellectual property in greater depth and why it’s important to act fast when patenting your product. Moving from Latin America to the United States, Gu...
2022-05-1853 min
The Best Of BioTech IQCan Hepion Pharmaceuticals Develop the First Treatment Approved For NASH? With Robert Foster, Pharm D, PhDOn this episode of BioTech IQ, Ammon Rivera interviews Robert Foster Pharm D, PhD, CEO of Hepion Pharmaceuticals. Robert brings 30 years of experience to this discussion and shares with us details of his background that led him to where he is today. We also discuss Hepion Pharmacetuicals current clinical trials to development treatments targeting chronic liver diseases including NASH, cancer, and chronic hepatitis virus infection. A quarter of the people in the US have fatty livers and of those, about a fifth will likely develop NASH. It’s a big problem that affects a lot of people. The company’s lead...
2022-04-3052 min
The Best Of BioTech IQHow Is Translational Genomics Reducing Background Noise In Multi-Disease Detection? With Aiguo "Adam" ZhangSome of the main problems with sequencing in identifying mutations are its cost and the time it takes. Fortunately, with the rapid growth of technology, revolutionary products that simplify processes are being made. One of those is from DiaCarta, a diagnostics company using translational genomics and molecular precision technology to develop ways of detecting disease. In this episode of BioTech IQ, Ammon Rivera interviews its CEO, Adam Zhang. Their patented technology reduces the "background noise" in testing, allowing for the detection of the "bad actor." Join in to learn the processes behind their work, what this means to the future o...
2022-04-1540 min
The Best Of BioTech IQAddressing One Of The World’s Biggest Drivers Of Disease: Inflammation With Jim Woody, M.D., Ph.D. - CEO 180 Life SciencesTNF is a protein that contributes to inflammation. Anti-TNFs can be used to stabilize this and stop the inflammation. It’s used for diseases like arthritis and psoriasis. Discover how clinical trials are done so these medicines and anti-TNFs can be utilized. Join Ammon Rivera as he talks to M.D., Ph.D. and CEO of 180 Life Sciences, Jim Woody about anti-TNFs and the trial process behind them. Jim’s goal is to address one of the biggest drivers of disease – inflammation. Learn more about Jim’s career as a venture capitalist. Find out why trials need to be uniform and randomi...
2022-04-0146 min
The Best Of BioTech IQ#35 Can Biomea Change the World with Irreversible Drugs and Covalent Bonds? Thomas Butler, CEO - Biomea FusionTom shares with us some of his journey and how that led him to co-found Biomea Fusion. We discuss some of the science behind irreversible drugs and covalent bonding. Using their fusion system there is greater potential for high selectivity, deep inactivation of target, and a greater therapeutic window.https://biomeafusion.com/https://thebiotechiqpodcast.com/podcast/
2022-01-041h 04
The Best Of BioTech IQ#33 Reducing friction at Clinical Trial Start-Up - Sam Searcy, CEO of CliniStartCliniStart launched to provide innovative tech-enabled solutions focused on global investigator contracts, budgets, and payments. And they did all of this just as the COVID-19 pandemic was hitting. This gave them an opportunity to shift and adapt. In this episode we address the challenges causing friction at during clinical trial start-up and what it takes to launch a start-up company.https://clinistart.com/
2021-12-1853 min
The Best Of BioTech IQ#32 People, the most valuable asset a business has. Brenda Sousa - Chief HR OfficerOn this episode we have Brenda Sousa, previously the Chief Human Resources Officer with Constellation Pharmaceuticals. Brenda shares with us part of her backstory and entry into the world of Biotech. We discuss people, culture, the function of HR, and how the industry requires a unique yet similar approach. Ammon also shares past experiences with Brenda and gets her take on them.#BiotechIQ #Biotech #Drugdevelopment #Recruiting #Staffing
2021-12-131h 04The Best Of BioTech IQ#31 Managing CRO relationships and unique business models - Stewart Hallet - COO SFJ PharmaceuticalsIn this episode of BioTech IQ Ammon interviews Stewart Hallet the COO of SFJ Pharmaceuticals, a specialty pharmaceutical company with a unique business model. The discussion touches on a number of things in clinical operations including working with CROs, leadership, and resourcing. #BioTechIQ #ClinicalOperations #DrugDevelopment #Podcasts
2021-11-241h 04
The Best Of BioTech IQ#30 Brazen Bio Part II - Live and In Person!Co-founders Shawn Carbonell and Brent Witgen discuss the progress of the 1st cohort (BRZN1) as they are well into the Brazen Bio program. We also get the chance to interview one of the founders currently in the program. We discuss what he is working on and what his experience has been in the program. Do you have a project that needs acceleration? Then don't hesitate, go to brazen.bio and get your application in for the next cohort.
2021-11-0440 minThe Best Of BioTech IQ#29 Why do we resist? Applying clinical psychology to clinical trials. Kathleen Starr, PhD - EVP Behavioral Insights, Syneos HealthKathleen shares fantastic insights on understanding behavioral psychology and how it applies to successful clinical trials. We had a great conversation that touched on increasing diversity in trials to understanding our own behavior and how we can potentially understand patients better. This can be applied in a way to close the gap between intention and action. Kathleen co-authored a Book called "Why We Resist: The Surprising Truths about Behavior Change: A Guidebook for Healthcare Communicators, Advocates and Change Agents" You can check it out at the link below. PSA: I have no sponsorships or financial agreements to promote the book...
2021-10-2957 minThe Best Of BioTech IQ#28 Vaccine Durability, Diversified Pipeline, Winning Strategy - Seth Lederman, MD - CEO Tonix PharmaceuticalsSeth Lederman is the CEO of Tonix Pharmaceuticals and a physician scientist with a two decades of research experience. Prior to becoming an entrepreneur, he was an Associate Professor at Columbia University. Dr. Lederman’s groundbreaking research led to the discovery of the CD-40 ligand and its role in T cell helper function. Currently, Dr. Lederman oversees Tonix Pharmaceuticals and its diverse programs that are aimed to develop therapeutics for chronic CNS and immunologic conditions, that include indications like fibromyalgia, Covid-19 and Long Covid, amongst others. Dr. Lederman earned an AB from Princeton University in Chemistry and an MD from Co...
2021-10-0156 minThe Best Of BioTech IQ#27 How do you effectively manage the CMC process? With Doug Looker, PhDDoug Looker is the VP of Operations with Validus Cellular Therapeutics. Validus is using cellular therapy to target infections by fighting the biology of antimicrobial resistance by activating the biology of the mammalian immune system. Doug walks us the through the process of establishing the CMC process that will drive success at every stage of the clinical trial process. And we have a brief discussion on animals being used in trials.During the recording and editing of this episode Doug was the VP of Preclinical Development and Manufacturing at Amicrobe, Inc. Therefore the intro does not reflect his...
2021-09-2129 minThe Best Of BioTech IQ#26 How do you know the right path of development? Mike Rea, CEO - IDEA PharmaMike is the CEO of IDEA Pharma and author of the Pharmaceutical Innovation Index. He just launched a new company, Protodigm, that’s mission is to act as a pharma/biotech skunkworks that can test and troubleshoot drug development and avoid failure by determining the best possible development paths. Here’s the release. He is an expert on all things drug development and has positioned 8 of the 15 biggest drug launches of the last 5 years. Mike is a contributor to Fortune, STAT, and Endpoints and also hosts his own podcast. https://podcast.ideapharma.com/Mike also refers to Protodigm as a next...
2021-09-0154 minThe Best Of BioTech IQ#25 Potential Tumor Immunity? Grant Yonehiro, CBO - Bolt BioTherapeuticsGrant is the Chief Business Officer with Bolt BioTherapeutics. Bolt Bio recently went public in February this year and announced a partnership with Genmab. Grant talks business development strategy and helping to navigate Bolt through their recent milestones.Bolt Bio focuses on the development of ISACs – immune-stimulating antibody conjugates – which are anti-cancer drugs comprised of two main parts: a tumor targeting antibody attached to an immune system stimulant. This stimulant activates both the innate and adaptive arms of the immune system, potentially turning a “cold” tumor environment into a “hot” one. Their lead therapeutic candidate, BDC-1001, targets HER2+ tumors and i...
2021-08-1152 minThe Best Of BioTech IQ#24 A fellowship program for biotech founders? Meet: Brazen BioThe founders of Brazen Bio discuss how their program is helping potential biotech founders prove their concepts and launch their company. Be Brazen!Shawn Carbonell, MD, PhD quit his neurosurgery residency to found his first biotech startup a decade ago. He had invented and developed a first-in-class cancer drug which is currently in phase 1 clinical trial.Brent Witgen, PhD had been in big pharma for the past decade, with direct involvement in over a dozen drug and device regulatory filings across multiple areas of human disease. He has built high-performing biotech teams in the US, EU, and Asia...
2021-07-1738 minThe Best Of BioTech IQ#23 Targeting treatment related toxicities - Michael McCullar - CEO OnQuality PharmaceuticalsMike discusses the advancements that OnQuality Pharmaceuticals is making toward to the treatment of toxicities caused by cancer treatments. Mike also shares with us the challenges and importance of strong leadership in our evolving workforce. https://twitter.com/onquality_rxhttps://www.linkedin.com/company/onquality-pharmaceuticals-ltd/https://www.onqualityrx.com/
2021-07-1047 minThe Best Of BioTech IQ#22 Regulatory Affairs Strategy w/Dr. Jethro Ekuta - VP, Global RADr. Ekuta helps to educate us on the function of regulatory affairs by sharing an acronym he calls RCI. Regulatory Requirements, Compliance, and Interaction. He shares how regulatory affairs professionals can had value to companies at all stages of the process, pre-clinical to post-market. Dr. Ekuta is currently the VP of Global Regulatory Affairs with Alexion Pharmaceuticals and is an accomplished RA and pharmacovigilance executive. Learn some of his secrets to regulatory strategy.
2021-06-2559 minThe Best Of BioTech IQ#21 Research and Development Tax CreditsLet's talk a little bit of tax and financial strategy! On this episode we have guests Derick Van Ness, a tax/financial strategist and owner of Big Life Financial and Justin Maxwell, President of Small Business Incentive Consultants. They discuss in further detail section 41 of the IRS tax code which cover R&D tax credits.
2021-06-1236 minThe Best Of BioTech IQ#20 Can longevity really be extended? Eric Leire, MD - CEO GenFlow BiosciencesDr. Leire discusses some of his background and the amazing things that GenFlow Biosciences are doing to develop gene therapies that slow or reverse aging in humans an dogs.
2021-05-0749 minThe Best Of BioTech IQ#19 Bing Du, MD - Senior Director, Global Patient Safety - BeiGene, Ltd.Dr. Du shares how he was chosen to study medicine in China and how he immigrated to the United States for a research fellowship. He subsequently went into industry and drug safety. We discuss some of the details and nuances of the medical case review side of drug safety.
2021-04-0848 min
The Podcast IndustryEpisode 26: "Profound Podcasting Secrets" - w/ Daniel J. LewisWe sit down with award-winning podcaster, Daniel J. Lewis (The Audacity to Podcast) to discuss SEO tips for getting your show discovered, how to refine your approach to podcasting, and create content for an existing fan base.
2021-04-0727 minThe Podcast IndustryEpisode 25: "Underpromise and Overdeliver on your Podcast" - w/ Ray OrtegaWe sit down with Ray Ortega (Podcasters' Roundtable) to talk about what is happening in the podcast industry, simple steps every podcaster can take to improve their show, and how there is no secret sauce to creating a successful podcast.
2021-03-3128 minThe Best Of BioTech IQ#18 Ed Tucker, MD, MBA - Chief Medical Officer - Mirum PharmaceuticalsDr. Tucker shares insight from his career on leadership to team building. He also discusses some of the the great things Mirum is doing to fight rare liver diseases in children.
2021-03-1843 minThe Podcast IndustryEpisode 24: "Sounds Profitable" - w/ Bryan BarlettaWe sit down with Bryan Barletta (Sounds Profitable) to talk about what is happening in the Podcast AdTech space, the importance of knowing why you want to start a podcast, and what shows we are listening to.
2021-03-0325 minThe Best Of BioTech IQ#17 Patti Engel - CEO of Engage Health Discusses Rare DiseasePatti started in the Rare Disease space back when it wasn't as well known. Her career led her to founding Engage Health a company that is helping to solve some of the unique challenges faced with patient recruitment in Rare Disease.
2021-02-2447 minThe Podcast IndustryEpisode 23: "Goodpods" - w/ JJ RambergWe sit down with JJ Ramberg (Goodpods) to talk about how under the radar podcasts are finding an audience on Goodpods, career advice, and why discoverability is such a problem for podcasters.
2021-02-2418 minThe Best Of BioTech IQ#16 Amy Baxter, MD, FAAP, FACEP - Founder and CEO of Pain Care LabsDr. Baxter practiced pediatric emergency medicine which led her to discover a common challenge people face; fear of needles and needle pain. She went on to develop a medical device called Buzzy. This has now evolved into another device called VibraCool that can be used to help people deal with pain. An interesting fact, Dr. Baxter was a guest season 5, episode 8 of Shark Tank. She actually turned the sharks down. And has continued find success in growing Pain Care Labs. Her device is also used in many clinical trials by multiple well pharmaceutical companies. Listen to hear the whole story!
2021-02-1449 minThe Podcast IndustryEpisode 22: "Podnews" - w/ James CridlandWe sit down with James Cridland (Podnews) to talk about how podcast hosts can connect with their audience, the mergers and acquisitions in the podcast space, and if Clubhouse will have an impact on the podcast industry.
2021-02-1020 minThe Podcast IndustryEpisode 21: "How to Grow Your Podcast" - w/ Dave JacksonWe sit down with Dave Jackson (School of Podcasting) to talk about the steps every podcaster should take, debunking the myths around how to profit from your podcast, and the biggest aspect of the industry that has changed since 2005.
2021-02-0333 minThe Best Of BioTech IQ#15 David Chonzi, MD - Global Head of PVE with Instil BioDr. Chonzi started his career in pharma/biotech as a drug safety physician learning both pre and post-market PV. Since then he has gained a large amount of experience helping companies develop their PV/drug safety function in the pre NDA and the NDA submital stages of the clinical trial process. In this episode of BioTech IQ he shares detailed insight into pharmacovigilance in the pre-market phases the clinical trial process.
2021-01-3044 min
Podcasting ResourcesPodgo Monetizing Smaller Podcast AudiencesPODGO helps brands and marketers connect with podcasts that have a highly engaged, highly targeted audience.From their Linkedin page:So you bought a microphone, paid for a hosting service, and found the best editing software…now what?PODGO is a platform made for small podcasts that average under 5,000 listeners per episode. We connect you with advertisers looking to tap into micro markets with dedicated listening. The way PODGO works is we review each applicant and accept those that meet our criteria to become a member. Member podcasts have access to available ad po...
2021-01-2704 minThe Best Of BioTech IQ#14 Juliana Oliveira, MD, PhD - VP Clinical Development, Viking TherapeuticsDr. Oliveira discusses some of her background and uses her wealth of knowledge in drug development to discuss the development of a phase III clinical trial.
2021-01-2147 minThe Podcast IndustryEpisode 20: "What's to come in 2021" - December 23rdDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual
2020-12-2309 minThe Podcast IndustryEpisode 19: "Best Podcasts of 2020 " - w/ Eliana DocktermanWe sit down with Eliana Dockterman (TIME) to talk about the top podcasters of the year, her view on celebrity podcasts, and how much content is too much content
2020-12-1821 minThe Podcast IndustryEpisode 18: "Don’t think about what you can’t do " - w/ Jason FeiferWe sit down with Jason Feifer (Entrepreneur) to talk about how to manage your time, tips on starting a podcast, and how the process for improving your work never ends.
2020-12-1421 minThe Podcast IndustryEpisode 17: "Indie Podcast Networks" - December 9thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual
2020-12-0907 minThe Best Of BioTech IQ#13 Jo Bhakdi - Founder and CEO of QuantgeneQuantgene has combined precision genomics, machine learning, and a new perspective to detect cancers at early stages. By doing this they have brought one of the biggest needle movers to the market for beating cancer, catching it at an early enough stages for treatments to be effective. Jo discusses some of the science, approach, and system his company is taking to advance a new model for early cancer detection. Join us for the full episode!
2020-12-0534 minThe Podcast IndustryEpisode 16: "Podcast Equipment " – w/ Parker HallWe sit down with Parker Hall (WIRED) to talk about what podcast gear he recommends using, his process for reviewing products, and the proper way to play a vinyl record.
2020-12-0222 minThe Podcast IndustryEpisode 15: "Big names on the move" - November 25thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual
2020-11-2509 minThe Best Of BioTech IQ#12 James Kirwin - COO SFA Therapeutics and Experienced Clinical Operations ExpertJames Kirwin has worked for some of the most well-known and successful large pharma organizations and successful start-up biotech firms. He has been on the front lines and cutting-edge of clinical operations strategy and has been directly part of multiple treatments on market today. Join us for a discussion on the other critical half of drug development: Clinical Operations.
2020-11-2346 minThe Podcast IndustryEpisode 14: “Marketers and Brands Approach to Podcasts" – w/ Jeff BeerWe sit down with Jeff Beer (Fast Company) to talk about how marketers and brands are approaching podcast advertising, the maturing habits of podcast listeners, and how increased investments in the podcast space will impact advertising opportunities.
2020-11-2021 minThe Podcast IndustryEpisode 13: “Good stories will always be good stories” – w/ Sam SteinWe sit down with Sam Stein (The Daily Beast) to talk about how podcasting has changed how we all get our news, what makes a good story, and what it was like to be on-stage for a live taping of Lovett of Leave It.
2020-11-1624 minThe Best Of BioTech IQ#11 Michelle McGuinness - Pharmaceutical Compliance PartnersMichelle has as a long and successful history leading compliance, quality assurance, and regulatory affairs. She discusses the difference between QA and Regulatory Affairs and how they affect both clinical trials and commercialization. Michelle also shares part of the story about her father who suffered from CADASIL syndrome, a rare disease that has no treatment, and how that inspired her throughout her career to make key decisions in her life. She has worked for well both well-known generics companies such as Mylan and big pharma companies such as AstraZeneca and Sanofi. Join for the journey and to learn a few...
2020-11-1452 minThe Podcast IndustryEpisode 12: "Podcast Paywalls" - November 11thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-11-1110 min
The Best Of BioTech IQ#10 Aleisha Dobbins, PhD, MBA - QA and GCP ConsultantAleisha shares how she became an expert consultant in helping clients with GCP Auditing, building functioning QA operations, and getting them inspection ready. All critical functions to not only manufacturing but running successful clinical trials as well.
2020-11-0740 minThe Podcast IndustryEpisode 11: "Bet on Podcasts" - November 4thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-11-0407 minThe Best Of BioTech IQ#9 Salah Kivlighn, PHD - The Kivlighn GroupDr. Kivilghn is a senior Pharmaceutical and biotech executive with a rare blend of science and business acumen. Dr. Kivlighn discusses what drove him into the industry, controversial challenge trials, and how having a science background contributed to successfully commercializing multiple drugs. Some of those drugs include Losartan (Cozaar®), a market-leading antihypertensive drug becoming a $3.5B franchise (Merck & Co.) and RotaTeq®, a required vaccine for children in the US, resulting in an $800M franchise (Merck & Co.)Very interesting insights shared!
2020-10-3149 minThe Podcast IndustryEpisode 10: Guy RazWe sit down with Guy Raz to talk about his advice for podcasts looking to grow their audience. Raz has been described by The New York Times as “one of the most popular podcasters in history” and his podcasts have a combined monthly audience of 19.2 million downloads. He is the co-creator of three NRP programs: How I Built This, TED Radio Hour, and Wow in the World.
2020-10-2930 minThe Podcast IndustryEpisode 9: "Another Acquisition" - October 28thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-10-2806 minThe Best Of BioTech IQ#8 Rolf Linke, MD - Chief Medical Officer - SFJ PharmaceuticalsDr. Linke shares his wealth of global drug development knowledge by discussing clinical trials and interacting with US, European, Chinese, and other regulatory agencies! Dr. Linke also shares his career progression and what drove some of the decisions he made that led to his current role. Being the Chief Medical Officer located in Germany with the company headquartered in California, you can bet he gets his share of travel and late nights.
2020-10-2351 minThe Podcast IndustryEpisode 8: "Listenership Is Up" - October 21stDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-10-2105 minThe Best Of BioTech IQ#7 Gwen Nichols, MD - Chief Medical Officer - The Leukemia & Lymphoma SocietyA trained Oncologist and physician scientist Dr. Nichols discusses what she has seen from working as an academic in research on the front lines as a principal investigator to transitioning into pharma and now in the non-profit setting.
2020-10-1651 minThe Podcast IndustryEpisode 7: "Back With A Vengeance" - October 14thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-10-1407 minThe Best Of BioTech IQ#6 Doniel Jackson, MD - Head of Drug Safety and Pharmacovigilance - MEI PharmaDoniel Jackson, MD is a 24+ year Drug Safety and PV veteran in the pharmaceutical industry. Dr. Jackson and I discuss aspects of Drug Safety and Pharmacovigilance and how it is a critical part to successful submission, registration, and post-marketing.
2020-10-0954 minThe Podcast IndustryEpisode 6: "Not So Exclusive After All" - October 7thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-10-0707 minThe Best Of BioTech IQ#5 Gurdyal Kalsi, MD - Chief Medical Officer - Asklepion PharmaceuticalsDr. Kalsi shares some insight on the difference between vaccine clinical trials vs. rare disease vs. oncology. While practicing medicine, experiences working as a principal investigator drove Dr. Kalsi to pursue a medical degree in pharmaceutical medicine and join the industry. Over 20 years later Dr. Kalsi shares some of what he's learned.
2020-10-0237 minThe Podcast IndustryEpisode 5: "International Podcast Day" - September 30thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-09-3007 minThe Best Of BioTech IQ#4 Ross O. Youngs - Founder and CEO of Biosortia PharmaceuticalsThrough an interesting turn of events Biosortia discovered they had access to large amounts of Aquatic Microbiome. With a broad range of capabilities they are able to extrapolate this into drug discovery. Ross believes that Biosortias ability to mine microbiome on such a large scale will change drug discovery in the coming years.
2020-09-2546 minThe Podcast IndustryEpisode 4: "Here Comes Amazon" - September 23rdDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-09-2309 minThe Podcast IndustryEpisode 3: "More Transparency in Podcasting" - Week of September 16thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-09-1609 minThe Best Of BioTech IQ#3 Dana Dornsife - CEO Lazarex Cancer FoundationWhen Dana's brother-in-law was diagnosed with pancreatic cancer she helped her family discover the power of access to clinical trials. That led her founding Lazarex Cancer Foundation, a non-profit organization that helps people find clinical trials and deal with the costs associated. Dana has literally worked to induce change on how the FDA views reimbursements to patients from pharma companies and her foundation is doing some amazing things to further diversity. Listen for the whole story!
2020-09-1052 minThe Podcast IndustryEpisode 2: "Community Not Celebrity" - Week of September 9thDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 stories from around the podcast industry in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-09-0907 minThe Podcast IndustryEpisode 1: "Welcome to the Podcast Industry" - Podcasting in the first week of SeptemberDigestible podcast news. Get smarter fast with an entertaining breakdown of our top 3 podcast industry stories in under 15 minutes. Pairs perfectly with your commute, workout, or morning oatmeal ritual.
2020-09-0208 minThe Best Of BioTech IQ#2 Guillermo Morales - CEO InnoventyxDr. Morales discusses how COVID-19 affects the clinical trial supply chain, IP Strategy, and transitioning from pre-clinical to clinical.
2020-08-2838 minThe Best Of BioTech IQ#1 Steven Norton - Chief Drug Development Officer - Elevar TherapeuticsSteve discusses adapting to COVID-19, hiring, and the challenges of drug development
2020-08-1434 minThe Podcast IndustryTrailerJoin us each week to breakdown the news happening in the podcast industry!
2020-08-1201 minThe Best Of BioTech IQComing Soon: Biotech IQOn August 14, 2020, Identifyd Life Sciences launches, Biotech IQ hosted by Ammon Rivera. A podcast that interviews those at the cutting edge and front lines of drug development. Ammon interviews people from all aspects of biotech and pharma!
2020-08-0401 min